Register Login

Abiopharma

  • Home
  • About
  • Newsroom
    • News
    • Company List
  • Events
  • Automated Tools
  • Contact

News list

PRINSTON INC

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 39
  • 0 comments

FDA approve DONEPEZIL HYDROCHLORIDE

Comment Full text

MSN

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 32
  • 0 comments

FDA approve PRAZOSIN HYDROCHLORIDE

Comment Full text

BARR

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 48
  • 0 comments

FDA approve MEDROXYPROGESTERONE ACETATE

Comment Full text

MYLAN

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 35
  • 0 comments

FDA approve EMTRICITABINE; TENOFOVIR DISOPROXIL FUMARATE

Comment Full text

LUPIN LTD

  • FDA Approval
  • Sept. 19, 2024, 08:42 UTC
  • 36
  • 0 comments

FDA approve BUMETANIDE

Comment Full text

LEADING

  • FDA Approval
  • Sept. 19, 2024, 04:10 UTC
  • 38
  • 0 comments

FDA approve METYROSINE

Comment Full text

ENDO OPERATIONS

  • FDA Approval
  • Sept. 18, 2024, 08:40 UTC
  • 36
  • 0 comments

FDA approve BOSENTAN

Comment Full text

NATCO PHARMA LTD

  • FDA Approval
  • Sept. 18, 2024, 08:40 UTC
  • 35
  • 0 comments

FDA approve BOSENTAN

Comment Full text

WATSON LABS INC

  • FDA Approval
  • Sept. 18, 2024, 08:40 UTC
  • 30
  • 0 comments

FDA approve BOSENTAN

Comment Full text

HETERO LABS LTD V

  • FDA Approval
  • Sept. 18, 2024, 08:40 UTC
  • 35
  • 0 comments

FDA approve SIROLIMUS

Comment Full text
  • Previous
  • 307
  • 308
  • 309
  • 310
  • 311
  • Next

Search

News categories

  • Technical Exchange News(10609)
  • Event(2026)
  • SEC News(185017)
  • FDA Approval(9858)
  • Company Report(721)
  • Business News(122533)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin